Saturday, 10 October 20264:17 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral

Image: Pharmtech. Rights remain with the publisher.

The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.

Read the full report on Pharmtech

Story file

Section
Health
Topics
Health alerts
First reported by
Pharmtech
Reporter
zachary zubulake
Published
Saturday, 10 October 2026, 1:57 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Pharmtech with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all